Veracyte announced that five abstracts providing new molecular insights into prostate and other cancers will be presented at the 2023 American Society of Clinical Oncology Annual Meeting, taking place in Chicago and online June 2-6. Three of the accepted abstracts leverage Veracyte’s Decipher GRID, Genomic Resource for Intelligent Discovery, database to explore potential opportunities for further personalizing treatment for patients with prostate cancer.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on VCYT:
